PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 101 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $145,000 | -22.0% | 70,025 | +16.7% | 0.00% | -100.0% |
| Q2 2020 | $186,000 | -9.3% | 60,025 | -33.3% | 0.00% | 0.0% |
| Q1 2020 | $205,000 | -37.7% | 90,025 | -0.8% | 0.00% | 0.0% |
| Q4 2019 | $329,000 | +0.6% | 90,773 | -5.2% | 0.00% | 0.0% |
| Q3 2019 | $327,000 | -21.6% | 95,773 | +7.9% | 0.00% | 0.0% |
| Q2 2019 | $417,000 | +39.5% | 88,773 | -0.7% | 0.00% | 0.0% |
| Q1 2019 | $299,000 | +26.2% | 89,373 | +0.4% | 0.00% | 0.0% |
| Q4 2018 | $237,000 | -52.5% | 89,025 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $499,000 | +10.6% | 89,025 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $451,000 | -21.3% | 89,025 | +6.0% | 0.00% | 0.0% |
| Q1 2018 | $573,000 | -2.7% | 84,025 | +7.7% | 0.00% | -33.3% |
| Q4 2017 | $589,000 | +55.0% | 78,025 | +18.2% | 0.00% | +50.0% |
| Q3 2017 | $380,000 | +15.5% | 66,025 | +1.6% | 0.00% | 0.0% |
| Q2 2017 | $329,000 | +110.9% | 65,000 | +8.3% | 0.00% | +100.0% |
| Q1 2017 | $156,000 | +140.0% | 60,000 | +29.6% | 0.00% | – |
| Q4 2016 | $65,000 | +75.7% | 46,300 | +131.5% | 0.00% | – |
| Q3 2016 | $37,000 | +362.5% | 20,000 | +300.0% | 0.00% | – |
| Q2 2016 | $8,000 | -20.0% | 5,000 | 0.0% | 0.00% | – |
| Q1 2016 | $10,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |